←
NickPowellLab523 posts
NickPowellLab avatar

NickPowellLab

@NickPowellLab

IBD research group at Imperial College London.

◷ Joined December 2017▧ 48 Photos and videos
Seb avatar
⟳ NickPowellLab retweeted
Seb@ibdseb·7 Nov 2025

Great progress in recruitment to @ACESO_ASUC this week with 7 patients randomised 📈 2 patients each included by @IbdHull & @imperialcollege teams 1 patient each included by teams from Manchester , Oxford , Leeds Thank you to participants and 🙏🏼🙏🏼to site teams for all the hard work We can 👌 do this in 🇬🇧- to make progress in a challenging phenotype of #IBD #Collaboration

Metabolism, Digestion & Reproduction avatar
⟳ NickPowellLab retweeted
Metabolism, Digestion & Reproduction@ImperialMDR·7 Nov 2025

MDR researchers launch a new trial, funded by @GSK, exploring improved vaccine responses in patients with inflammatory bowel disease #IBD (@NickPowellLab @IHepatology) Find out more ⬇️ imperial.ac.uk/news/271355/n…

Seb avatar
⟳ NickPowellLab retweeted
Seb@ibdseb·6 Nov 2025

Congratulations to @imperialcollege team led by Dr James Alexander & @NickPowellLab for randomising their first patient to @ACESO_ASUC study And they have done that within 2️⃣4️⃣hours of receiving green light !!! 🚦👏👏 Thanks to the participant and the entire team in particular research nurse Isabel Many more to come 🤞

Seb avatar
⟳ NickPowellLab retweeted
Seb@ibdseb·24 Jun 2025

Our eagerly awaited #RCT on #JAKis #Upadacitinib in Acute Severe Colitis is now recruiting The ACESO study @ACESO_ASUC ❇️Double blind placebo controlled ❇️ Upfront #upa + IV steroids Vs Iv steroids + Placebo ❇️Option for entry into rescue sub-studies for non responders 📢📣 3️⃣0️⃣ 🇬🇧 sites Say hello 👋 for updates if at #BSGLIVE25

Post attachmentPost attachment
St Mark's Hospital avatar
⟳ NickPowellLab retweeted
St Mark's Hospital@StMarksHospital·27 Feb 2025

Congratulations to Professor Ailsa Hart, IBD Research Lead at St Mark’s. 🌟 At ECCO 2025, Professor Hart presented the latest results of SC guselkumab for moderate to severe active Crohn’s disease at the prestigious Saturday plenary session. Following this, she was awarded the ECCO Global Grant on behalf of a global team of researchers to advance perianal Crohn’s disease research worldwide — a remarkable achievement driving innovation in IBD care. A fantastic recognition of her dedication to improving patient outcomes! 🙌🏻

Post attachment
Shomron Ben-Horin avatar
⟳ NickPowellLab retweeted
Shomron Ben-Horin@ShomronH·16 Nov 2024

Albeit retrospective, an important reassuring data on safety of GLP1s weight reduction in IBD. I tell my pts that Obesity+associated HTN/diabetes/hyperlipedmia end up killing far more IBD pts than (fortunately very very rare now) death d/t IBD itself. This is whats at stake !

Safety and Effectiveness of Glucagon-like Peptide-1 receptor agonists in #IBD: our experience @WashUMedIBD @WashUMedGastro led @MalekAyoubMD @SRAnderson121 #SarahCoats @AmJGastro journals.lww.com/ajg/abstrac…

NickPowellLab avatar
NickPowellLab@NickPowellLab·14 Sep 2024

Thank you Kate! And thank you for putting together a wonderful tour of the wineries of the Adelaide Hills! Beautiful country and wonderful wine! 🍇 🍷 😊 👏

Masterful Bushell Lecture by @NickPowellLab on his IBD mucosal immunology research - specifically, looking at IL-22 and its role in IBD - predicts response to ustekinumab, unregulates neutrophil attracting chemokines, among others. #AGW2024

Post attachmentPost attachmentPost attachment
WeersmaLab avatar
⟳ NickPowellLab retweeted
WeersmaLab@WeersmaLab·10 Jul 2024

Moving towards gut dysbiosis testing in cancer immunotherapy resistance. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome: Cell cell.com/cell/fulltext/S0092…

Open Targets avatar
⟳ NickPowellLab retweeted
Open Targets@OpenTargets·19 May 2024

On #WorldIBDDay, Open Targets project lead @anderson_carl introduces our most ambitious project yet: @OpenIBD!

Today is #WorldIBDDay 🌎 Check out our video with @anderson_carl to discover more about what IBD is and how @OpenIBD aims to find new ways to predict, monitor, and treat it.🔎 @OpenTargets @DrChrisLamb @UniofNewcastle @NewcastleHosps #IBDMythBusting sanger.ac.uk/news_item/ambit…

2:15